Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Inari Medical Inc (NARI)

Inari Medical Inc (NARI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Reasons to Retain Inari Medical Stock in Your Portfolio for Now

Inari Medical, Inc. NARI is well poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, the company’s dependency...

AXGN : 17.19 (+9.91%)
ARAY : 1.8700 (+1.08%)
MASI : 167.51 (-1.19%)
NARI : 53.24 (-3.99%)
Inari Medical Announces Joint Venture with 6 Dimensions Capital and VFLO Medical to Expand Access in Greater China

Inari Medical announces a joint venture with 6 Dimensions Capital and VFLO Medical to enhance healthcare access in Greater China.Quiver AI SummaryInari Medical, Inc. has announced a joint venture with...

NARI : 53.24 (-3.99%)
Inari Medical Receives National Reimbursement Approval for ClotTriever Thrombectomy System in Japan

Inari Medical received Japanese reimbursement approval for ClotTriever, enhancing DVT treatment options through a new functional category.Quiver AI SummaryInari Medical, Inc. announced that it received...

NARI : 53.24 (-3.99%)
Inari Medical Announces Reimbursement Approval for ClotTriever® Thrombectomy System in Japan and New Distribution Partnership with Medikit Co., Ltd.

NARI : 53.24 (-3.99%)
Inari Medical Announces Joint Venture in Greater China

NARI : 53.24 (-3.99%)
Insider Sale: President and CEO of $NARI (NARI) Sells 3,000 Shares

Andrew Hykes, the President and CEO of $NARI ($NARI), sold 3,000 shares of the company on 11-20-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.7% of their...

NARI : 53.24 (-3.99%)
Insider Sale: Director at $NARI (NARI) Sells 9,750 Shares

William Hoffman, a director at $NARI ($NARI), sold 9,750 shares of the company on 11-18-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.9% of their shares....

NARI : 53.24 (-3.99%)
Inari Medical to Participate in the Jefferies London Healthcare Conference

NARI : 53.24 (-3.99%)
PEERLESS Results Show Superiority of FlowTriever® Compared to Catheter-Directed Thrombolytics for Intermediate-Risk Pulmonary Embolism

NARI : 53.24 (-3.99%)
Inari Medical Reports Third Quarter 2024 Financial Results

NARI : 53.24 (-3.99%)

Barchart Exclusives

Why This Dividend Stock Just Scored a Rare Upgrade
Bristol Myers Squibb, a global biopharma company, has received a rare upgrade from Jefferies due to its promising pipeline and strategic partnerships. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar